Clinical and laboratory characteristics and outcome predictors of cerebral venous sinus thrombosis in a referral neurology hospital in Bangladesh

J Int Med Res. 2024 Aug;52(8):3000605241266550. doi: 10.1177/03000605241266550.

Abstract

Objective: We aimed to describe clinical and laboratory characteristics and determine the predictors of outcome in patients with cerebral venous sinus thrombosis.

Methods: This prospective study was conducted over 2 years among hospitalized patients with cerebral venous sinus thrombosis. Patient outcome was assessed using the Modified Rankin Scale (mRS) score at 3 months. Outcome predictors were identified using logistic regression analysis.

Results: Eighty-one patients were included in this study. The median mRS outcome at 3 months was 1 (interquartile range 1-3). Poor outcomes were observed in 27.2% of patients, and the mortality rate was 9.8%. Factors associated with poor outcomes were age >60 years (relative risk [RR] 5.1), hemiparesis (RR 5.4), altered level of consciousness (RR 7.1), and transverse sinus involvement (RR 1.1). In general, mRS scores were not associated with D-dimer levels (RR 2.4). However, older patients with elevated D-dimer levels showed a significant association with poor outcomes (1.6) according to mRS scores.

Conclusion: Older age, hemiparesis, and altered consciousness levels were independent predictors of poor outcomes in patients with cerebral venous sinus thrombosis. High D-dimer level showed no association with functional disability, except in older patients.

Keywords: Cerebral venous sinus thrombosis; clinical characteristic; laboratory parameter; older patient; patient outcome; predictor.

MeSH terms

  • Adult
  • Aged
  • Bangladesh / epidemiology
  • Female
  • Fibrin Fibrinogen Degradation Products* / analysis
  • Fibrin Fibrinogen Degradation Products* / metabolism
  • Humans
  • Male
  • Middle Aged
  • Paresis / etiology
  • Prognosis
  • Prospective Studies
  • Referral and Consultation
  • Risk Factors
  • Sinus Thrombosis, Intracranial* / diagnosis
  • Sinus Thrombosis, Intracranial* / mortality

Substances

  • fibrin fragment D
  • Fibrin Fibrinogen Degradation Products